YahooSeptember 15, 2026 at 11:11 AM NYLast Month
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
NRXS is benefiting from stronger IB-Stim volumes, broader reimbursement and VA access, but incomplete payer coverage and cash needs remain challenges.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
